Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Malignant Neoplasm
100%
Breast Cancer
94%
Pancreas Cancer
88%
Pancreas Adenocarcinoma
61%
Overall Survival
55%
Patient-Reported Outcome
53%
Diseases
40%
Prostate Cancer
39%
Neoplasm
39%
Primary Health Care
33%
Aromatase Inhibitor
33%
Acute Myeloid Leukemia
30%
Arm
29%
Comorbidity
27%
Clinician
26%
Chemotherapy
25%
Oncology
24%
Cancer Therapy
23%
Surveillance, Epidemiology, and End Results
22%
Colorectal Carcinoma
22%
Preventive Medicine
21%
Positron Emission Tomography-Computed Tomography
20%
Prevalence
20%
Fluorine-18
20%
Cancer
20%
Odds Ratio
20%
Prostate Specific Membrane Antigen
20%
Medicare
18%
Hazard Ratio
17%
Clinical Trial
17%
Chronic Obstructive Pulmonary Disease
16%
Hormone Therapy
16%
Survivorship in Cancer Care
16%
Positron Emission Tomography
16%
Event Free Survival
15%
Genetics
15%
Quality of Life
15%
Health Care Cost
15%
Randomized Controlled Trial
15%
Adjuvant Endocrine Therapy
15%
Cytarabine
15%
Conventional Imaging
15%
Computer Assisted Tomography
14%
Chemoradiotherapy
14%
Radiation Therapy
14%
Cancer Treatment
14%
Pancreatic Cysts
12%
Postmenopause
12%
Endoscopic Ultrasound
12%
Elderly Patient
12%
Keyphrases
Pancreatic Cancer
81%
Pancreatic Ductal Adenocarcinoma
66%
95% Confidence Interval
58%
Patient-reported Outcomes
50%
Acute Myeloid Leukemia
48%
Breast Cancer
44%
Overall Survival
39%
Survivors
33%
Cancer Survivors
33%
Hazard Ratio
30%
Survivorship Care Plan
30%
Patient-Reported Outcomes Measurement Information System (PROMIS)
30%
Phase I Study
30%
Newly Diagnosed
29%
Oncologists
29%
Tumor Marker
26%
Positron Emission Tomography/computed Tomography (PET/CT)
26%
Surveillance Epidemiology
26%
Clinical Practice
25%
High Risk
25%
Odds Ratio
24%
Supportive Care Needs
24%
Comorbidity
23%
Aromatase Inhibitors
21%
High-risk Individuals
21%
Cancer Care
21%
Cancer Patients
20%
Early Breast Cancer
20%
Quality of Care
20%
Older Adults
20%
Prostate-specific Membrane Antigen
20%
United States
19%
Pancreatic Adenocarcinoma
19%
Risk Factors
19%
Computed Tomography
18%
Breast Cancer Survivors
17%
Poor Risk
17%
Physical Function
17%
Chemotherapy
17%
Allogeneic Bone Marrow Transplantation
17%
Comorbid Conditions
16%
Vitamin D Supplementation
16%
Cancer Treatment
16%
Primary Care Providers
16%
Induction Chemotherapy
16%
Phase I Trial
16%
Event-free Survival
16%
Preventive Care
15%
Complete Remission
15%
Tumor
15%